| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 05/23/2012 | CN102470166A Dipeptidyl peptidase-4 inhibitor |
| 05/23/2012 | CN102470164A 以每周给药1次每次为100单位～200单位的pth为特征的、含有pth的骨质疏松症治疗/预防剂 Is administered once per week for every 100 units to 200 units pth characterized, osteoporosis containing pth / prophylactic agent for |
| 05/23/2012 | CN102470162A 用于治疗难治性c型慢性肝炎的药剂以及方法 The treatment of refractory chronic hepatitis c agents and methods for |
| 05/23/2012 | CN102470153A 氧化蛋白水解酶活性增强剂 Oxidation proteolytic activity enhancer |
| 05/23/2012 | CN102470145A 血中gip浓度上升抑制剂 Increased blood concentrations of inhibitors gip |
| 05/23/2012 | CN102470133A Quinoline derivative-containing pharmaceutical composition |
| 05/23/2012 | CN102470126A 用于治疗与异常肠胃运动有关的疾病的酸泵拮抗剂 Acid pump for the treatment of diseases related to abnormal bowel movements antagonist |
| 05/23/2012 | CN102470118A External preparation containing nsaids and method for producing the external preparation |
| 05/23/2012 | CN102470114A 口臭去除剂 Halitosis remover |
| 05/23/2012 | CN102466658A 一种注射剂中5-羟甲基糠醛含量的测定方法 An injection method for the determination of 5-HMF content |
| 05/23/2012 | CN102465146A 融合表达重组制备t4核酸内切酶v Recombinant fusion protein was prepared t4 endonuclease v |
| 05/23/2012 | CN102464718A 人源化之单克隆抗体、其氨基酸序列与核苷酸序列与其用途 Humanized monoclonal antibodies, amino acid sequence and the nucleotide sequence of its use |
| 05/23/2012 | CN102462837A Anti-inflammatory composition |
| 05/23/2012 | CN102462762A 一种陈皮提取物微丸及其制备方法 One kind of orange peel extract pellets and its preparation method |
| 05/23/2012 | CN102462745A 一种芍药提取物微丸及其制备方法 Herbaceous peony extract pellets and its preparation method |
| 05/23/2012 | CN102462726A 白树总生物碱及多羟基生物碱化合物的提取、分离及用途 White Tree total alkaloid extract and polyhydroxy alkaloid compounds, separation and uses |
| 05/23/2012 | CN102462725A 一种苦瓜提取物微丸及其制备方法 One kind of bitter melon extract pellets and its preparation method |
| 05/23/2012 | CN102462038A 清香保健帽子 Fragrance health Hat |
| 05/23/2012 | CN102114063B Method for extracting and separating asiaticoside by countercurrent extraction combined with membrane separation |
| 05/23/2012 | CN102068566B Detection method for Yinchen Wudan pills for treating damp-heat jaundice |
| 05/23/2012 | CN101991769B Traditional Chinese medicine composition for treating heart-kidney imbalance |
| 05/23/2012 | CN101979572B Preparation for South China Sea conus striatus toxin S4.3 and application |
| 05/23/2012 | CN101967138B Fatty acid schisantherin A ester compound |
| 05/23/2012 | CN101912399B Radiotherapy enhancer |
| 05/23/2012 | CN101862009B Health-care drink for eliminating hiccup, pain of chest and back and spasm of bowels and abdomen and preparation method |
| 05/23/2012 | CN101805337B Compound containing proline and isoxazole skeleton and preparation method and application thereof |
| 05/23/2012 | CN101514192B Quinoxalinone derivative with activity for reversing tumor cell multidrug resistance and preparation method thereof |
| 05/23/2012 | CN101426378B Use of glycerin compound in preparing medicine for treatment of poultry for increasing the feed conversion rate or for reducing the incidence of ascites |
| 05/23/2012 | CN101407539B Oligopeptide having marrow hemopoiesis protection function, preparation thereof, pharmaceutical composition containing the oligopeptide and use |
| 05/23/2012 | CN101347105B Method for using garlic in large scale ecological nursing short necked clam |
| 05/23/2012 | CN101282716B Pharmaceutical composition of pranlukast solid-dispersion with improved initial dissolution rate and the method of preparing the same |
| 05/23/2012 | CN101177438B N-acetylglucosamine derivatives and use thereof |
| 05/23/2012 | CN101171019B Immune function modulating agents |
| 05/22/2012 | US8183363 Antisense oligonucleotide modulation of STAT3 expression |
| 05/22/2012 | US8183273 Bicyclic compound, production and use thereof |
| 05/22/2012 | US8183232 Therapeutic agent for hemorrhoidal disease |
| 05/22/2012 | US8183226 Myocardial perfusion imaging method |
| 05/22/2012 | US8183213 Combination therapy comprising glucose reabsorption inhibitors and retinoid-X receptor modulators |
| 05/22/2012 | US8183208 Targeted delivery of drugs for the treatment of viral infections |
| 05/22/2012 | CA2560642C 5-aminoalkylpyrazole derivatives as pesticidal agents |
| 05/22/2012 | CA2531064C Novel heteroaryl derivative |
| 05/22/2012 | CA2458442C Pulsatile release compositions and methods for enhanced gastrointestinal drug absorption |
| 05/22/2012 | CA2449013C Viral mutants that selectively replicate in targeted human cancer cells |
| 05/22/2012 | CA2442326C Imidazolyl derivatives useful as histamine h3 receptor ligands |
| 05/22/2012 | CA2440214C Method of modulating the proliferation of medullary thyroid carcinoma cells |
| 05/22/2012 | CA2374964C Process for producing an injectable medicament preparation |
| 05/22/2012 | CA2336717C Immortalized human keratinocyte cell line |
| 05/18/2012 | WO2012063896A1 Novel pyrazole amide derivative |
| 05/18/2012 | WO2012063514A1 Attractant for bone marrow stem cells, and method for attracting bone marrow stem cells |
| 05/18/2012 | WO2012063513A1 Method of treatment for mental disorders |
| 05/18/2012 | WO2012063272A1 Defibrotide for use in prophylaxis and/or treatment of graft versus host disease (gvhd). |
| 05/18/2012 | WO2012062044A1 Small molecule inhibitor syntelin against kinetochore motor protein cenp-e and use thereof |
| 05/18/2012 | CA2814828A1 Method of treatment for mental disorders |
| 05/18/2012 | CA2813413A1 Defibrotide for use in prophylaxis and/or treatment of graft versus host disease (gvhd) |
| 05/17/2012 | US20120122984 Methods of Treating Lipomas and Liposarcomas |
| 05/17/2012 | US20120122982 Use of pufas to treat nerve damage |
| 05/17/2012 | US20120122957 Regulation of aging by modulation of mitochondrial function |
| 05/17/2012 | US20120122946 Polymorphisms for predicting disease and treatment outcome |
| 05/17/2012 | US20120122909 Spiro-oxindole compounds and their uses as therapeutic agents |
| 05/17/2012 | US20120122826 Novel quinuclidine derivatives and medicinal compositions containing the same |
| 05/17/2012 | US20120122824 Reduction of Side Effects From Aromatase Inhibitors Used for Treating Breast Cancer |
| 05/17/2012 | US20120122823 Aqueous drug delivery system |
| 05/17/2012 | US20120122816 Compositions and methods for organ preservation |
| 05/17/2012 | US20120122780 Compounds, Compositions and Methods for Modulating Uric Acid Levels |
| 05/17/2012 | US20120122770 Cell Cycle Arrest and Apoptosis |
| 05/17/2012 | US20120122220 Method and apparatus for maintenance and expansion of hemopoietic stem cells and/or progenitor cells |
| 05/17/2012 | US20120122111 Rna sequence-specific mediators of rna interference |
| 05/17/2012 | US20120122109 Neural progenitor cells derived from embryonic stem cells |
| 05/17/2012 | US20120121708 Acetazolamide Microparticle And Its Preparation Method And Use |
| 05/17/2012 | US20120121663 Treatment using dantrolene |
| 05/17/2012 | US20120121662 Treatment using dantrolene |
| 05/17/2012 | US20120121654 Nanoparticle isoflavone compositions & methods of making and using the same |
| 05/17/2012 | US20120121622 Biodegradable immunomodulatory formulations and methods for use thereof |
| 05/17/2012 | US20120121601 Mammalian receptor proteins; related reagents and methods |
| 05/17/2012 | US20120121591 SELECTIVE AND POTENT PEPTIDE INHIBITORS OF Kv1.3 |
| 05/17/2012 | US20120121584 Monoclonal Antibodies Against Extracellular Loops of C5aR |
| 05/17/2012 | US20120121565 Protein Recovery |
| 05/17/2012 | US20120121549 Induced pluripotent stem cells and methods of use |
| 05/17/2012 | US20120121531 Biocomposite for artificial tissue design |
| 05/16/2012 | EP2453010A1 Neural progenitor cells derived from embryonic stem cells |
| 05/16/2012 | EP2452944A1 Diphenyl sulfide derivatives and medicines containing same as active ingredient |
| 05/16/2012 | EP2452690A1 Carboxymethylarginine production inhibitor and collagen denaturation inhibitor |
| 05/16/2012 | EP2452680A1 Acid pump antagonist for treatment of diseases associated with abnormal gastrointestinal movement |
| 05/16/2012 | EP2451457A1 Pharmaceutical compositions and therapeutic methods employing a combination of a manganese complex compound and a non-manganese complex form of the compound |
| 05/16/2012 | EP2451299A1 Methods and compositions for treating thyroid-related medical conditions with reduced folates |
| 05/16/2012 | CN202219033U A device employing traditional Chinese medicine to treat complicating diseases of gallbladder channel and spleen channel |
| 05/16/2012 | CN1575338B Bv8 nucleic acids and polypeptides with mitogenic activity |
| 05/16/2012 | CN102459588A Aptamer for chymase, and use thereof |
| 05/16/2012 | CN102459231A 季铵盐化合物 Quaternary ammonium compounds |
| 05/16/2012 | CN102459221A 噻吩衍生物 Thiophene derivative |
| 05/16/2012 | CN102459218A 凝集素样氧化型ldl受体抑制用医药品以及动脉硬化预防医药品 Lectin-like oxidized ldl receptor inhibition with pharmaceuticals pharmaceuticals and atherosclerosis prevention |
| 05/16/2012 | CN102459198A Crystals |
| 05/16/2012 | CN102459185A 新型甲状腺激素β受体激动剂 Novel thyroid hormone receptor β agonists |
| 05/16/2012 | CN102459172A 四环化合物 Tetracyclic compounds |
| 05/16/2012 | CN102458579A 吡嗪并氧氮杂*衍生物 Pyrazino oxazepin * Derivatives |
| 05/16/2012 | CN102458472A Pharmaceutical composition, food or beverage, and methods for these products |
| 05/16/2012 | CN102458428A Nfat signal inhibitor and calcineurin inhibitor |
| 05/16/2012 | CN102458421A Medicinal agent |
| 05/16/2012 | CN102458417A Enhancer of activity of nucleic acid analogue |
| 05/16/2012 | CN102458406A Oral liquid preparation |